Ebon Lupus Article

Osteoarthritis Learn How It Affects The Human Body
By Jack Harmon

Osteoarthritis defines the failure of the synovial lined, movable joint. The basic factor in Osteoarthritis is the destruction of the articular cartilage that lines the facing side of the bone that forms a joint.

In Idiopathic or Primary Osteoarthritis, which is the most common form of the disease, no definite predisposing factor is established.

Secondary Osteoarthritis is completely distinguishable from the primary Osteoarthritis. There is some disease that leads to is formation.

Osteoarthritis is, by far, the most common arthritis disease of the human and more than 100, 000 persons in the United States are so crippled by this disease that they are unable to go to toilet from the bed.

Age is the most prominent risk factor for the disease. Researchers have found that, among women below 45 years of age, only 2% were suffering from it.

Between the ranges of 45 to 64 years, the prevalence is 30% and over the age of 65 years, the rate is more than 68%.

Major bodily injury and repetitive use of the joint are the next common culprits. Meniscus damage and or Anterior Crutiate Ligament injury can lad to knee Osteoarthritis - the joint mostly involved.

Obesity is a substantial risk factor for both hand and knee Osteoarthritis. It as noted that mere reduction of 5 kilo weight lowers the odds ratio of potential chance to having Osteoarthritis by 50%.

Sometimes the role of heredity as a risk factor for developing the disease is mentioned. It is noticed that the mother and the sister of a woman with DIP (Distal Interphalangeal Joint) Osteoarthritis (Heberden's nodes) are two to three times risk of developing Osteoarthritis in the same joints.

It is stressed that Osteoarthritis is the destruction of the articular cartilage of a joint. But it is not the whole scenario.

In Osteoarthritis, the entire joint is affected- the synovium, subchondral bones, the menisci, ligaments and the surrounding neuromuscular tissues.

The main clinical finding in Osteoarthritis is acute pain in the affected joint. Nocturnal pain, hampering the sleep process is seen in the advanced hip Osteoarthritis and may be debilitate a patient.

Stiffness of the joint occurs as there is inactivity. Joint instability, because of stretching of the capsule of the joint occurs besides muscle spasm.

The diagnosis of the Osteoarthritis is usually dependent on clinical and radiological finding. In early stages, the radiography may be normal except there is some loss in the joint space. Gradually there is formation of osteophytes and subchondral sclerosis.

No laboratory tests are useful to diagnose a case of the disease except to determine the cause in the secondary Osteoarthritis.

Treatment of Osteoarthritis is intended towards relieving pain, preserving joint mobility and reducing disability.

The first option is weight reduction. As the joints become weak in Osteoarthritis, they can not bear the same weight as they were used to. Losing some weight lowers the load to a particular joint, thus improving the pain situation.

Patellar taping is a less expensive, useful way of reducing pain. Mere taping over the patella with some isometric exercises improves the power of the muscles around the knee joint.

This in turn helps to qualitative weight bearing capacity of the joint. Hot fomentation and cold compress are equally effective to reduce pain. Rational engagement in exercise can control it a lot.

Among the medication, the first line of therapy consists of using NSAIDs (Non Steroidal Anti Inflammatory Drugs).

The newer generation Selective COX-2 inhibitors are doing a good job in effective controlling of pain and reducing the incidence of Acid Peptic disorder.

Invasive methods of treatment include Intra-articular injection of Steroidal component and Hyaluronan.

To learn how to reduce the pain of Osteoarthritis check out Osteoarthritis arthritis pain relief

Recommended Products



____________________


Arthritis image 1

Arthritis image 2

Related Ebon Lupus Videos


Ebon Lupus News


Skyepharma PLC announces European Product Approval - CNNMoney.com


Skyepharma PLC announces European Product Approval
CNNMoney.com - 17 hours ago
This night-time release formulation is especially suited to the treatment of early morning stiffness, which is associated with rheumatoid arthritis, ...

Read more...


Adolescents with arthritis need more information when ... - PhysOrg.com


Adolescents with arthritis need more information when ...
PhysOrg.com, VA - 5 hours ago
Helping adolescents with arthritis develop the skills and secure resources to assure that their health care needs are met as they transition to adulthood is ...

Read more...


Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid ... - PR Newswire (press release)


Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid ...
PR Newswire (press release), NY - 10 hours ago
The November 2008 IND filing enables Velcura to proceed with clinical trials in patients with stable Rheumatoid Arthritis. A small, orally available ...

Read more...


Self-Help for Arthritis Sufferers - Edge


Self-Help for Arthritis Sufferers
Edge, FL - 7 hours ago
What is arthritis? This e-mail address is being protected from spambots. You need JavaScript enabled to view it NEW SMYRNA BEACH – This word comes from the ...

Read more...


Calm your arthritis without medications or therapy - Examiner.com


Examiner.com

Calm your arthritis without medications or therapy
Examiner.com - 11 hours ago
by Peggy Kraus, Disease Prevention Examiner Limiting, deforming, bothersome, and often painful arthritis can be more than a nuisance. ...

Read more...


Synta Pharmaceuticals forms alliance with Roche - Boston Globe


Synta Pharmaceuticals forms alliance with Roche
Boston Globe, United States - 11 hours ago
... alliance to discover, develop, and commercialize small-molecule drugs to treat rheumatoid arthritis and a broad range of other inflammatory diseases. ...
Synta to develop anti-inflammatory drugs for Roche Forbes
Synta and Roche Form Discovery, Development, and Commercialization ... Earthtimes (press release)
Synta and Roche Ink Billion-Dollar Inflammatory Disease Deal Genetic Engineering News (press release)
RTT News
all 20 news articles

Read more...


New therapy helps boy with rare disease - Reuters


New therapy helps boy with rare disease
Reuters - 23 minutes ago
By Julie Steenhuysen CHICAGO (Reuters) - A drug used to suppress the immune system in cancer and rheumatoid arthritis has helped extend the life of a ...

Read more...


Ebon Lupus Links

Blinkx Video Search
World's largest video search engine. Over 26 million hours of video.
www.blinkx.com

redOrbit.com -- Science, Health, Technology Videos
redOrbit.com is a science, health, and technology news and information portal. Learn something new today!
redorbit.com

Search Jobs on Yahoo! HotJobs
Search Jobs by Location, Industry or Keyword
www.hotjobs.com

Arthritis Facts
Get facts about arthritis treatment, causes, diagnosis & more.
arthritis-faq.org

Arthritis Pain Relief
Symptoms, causes, treatments of Arthritis Pain Relief
myoptumhealth.com

MPAA
An ongoing story about MPAA extortion attempts.